Quality Assurance Scheme Development Group
The Quality Assurance Scheme Development Group (QASDG) will develop the European Quality Assurance Scheme for Breast Cancer Services (the European QA scheme) to set common quality and safety requirements for person-centred breast cancer services in Europe. The scheme will cover all the processes of breast cancer care (screening, diagnosis, treatment, rehabilitation & supportive care, follow-up & survivorship care and palliative care) and will be underpinned by the accreditation legal framework and evidence from guidelines.
The QASDG discusses and selects the requirements within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before piloting are subject of open calls for feedback launched online. After piloting, the so validated scheme will become operative on voluntary basis throughout Europe.
The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care).
The QASDG is supported by the external contractors EA- European Co-operation for Accreditation for the accreditation legal framework and for the coordination of national accreditation bodies, by CCIb –Iberoamerican Cochrane Centre for literature review and by IQ healthcare to develop indicators.
Members and external experts
Luzia Travado, PhD, MSc, ClinPsych, is clinical health psychologist and psychotherapist by the University of Lisbon, specialized in psycho-oncology and palliative care, and has doctorate degree in Psychology/Health Psychology by the University of Coimbra.
She is presently head of Psycho-Oncology at the Clinical Center of the Champalimaud Foundation (www.fchampalimaud.org), in Lisbon, Portugal (2012-).
Previously was chief of Clinical Psychology at Central Lisbon Hospital Centre-Hospital S. José, where she began her career and has pioneered psychosocial programs for chronic disease patients, namely breast cancer (1985-2012).
She served as adviser for the National Coordinator for Oncological Diseases in Portugal (2007-2011).
She represented Portugal at the European Partnership on Action Against Cancer (2009-2014), and led the Psychosocial Oncology Action under this partnership; she presently collaborates with the European Cancer Control Joint Action (CANCON).
She has been involved in European cancer policy being a speaker at various EU meetings, summits and conferences concerning cancer control and care in Europe, and also international ones related to psycho-oncology.
She currently serves as President of the International Psycho-Oncology Society (www.ipos-society.org), and was Chair of the IPOS World Congress of Psycho-oncology in Lisbon in 2014.
She serves as Specialty-editor for The Breast and is founder and former president of the Viva Mulher Viva Association on breast cancer.
She has several scientific papers published in Int’l peer-review journals, and book-chapters.
She was cover story at Cancer World in the Nov-Dec 2011 issue.